000 01215 a2200301 4500
005 20250516090202.0
264 0 _c20120710
008 201207s 0 0 eng d
022 _a1524-4636
024 7 _a10.1161/ATVBAHA.112.245571
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFazio, Sergio
245 0 0 _aInhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeutics.
_h[electronic resource]
260 _bArteriosclerosis, thrombosis, and vascular biology
_cMay 2012
300 _a1060-2 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Comment
650 0 4 _aAnimals
650 0 4 _aApolipoproteins A
_xgenetics
650 0 4 _aAtherosclerosis
_xgenetics
650 0 4 _aFemale
650 0 4 _aFibroblast Growth Factors
_xmetabolism
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aRNA, Messenger
_xgenetics
700 1 _aLinton, MacRae F
773 0 _tArteriosclerosis, thrombosis, and vascular biology
_gvol. 32
_gno. 5
_gp. 1060-2
856 4 0 _uhttps://doi.org/10.1161/ATVBAHA.112.245571
_zAvailable from publisher's website
999 _c21716587
_d21716587